Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

148 PROCARE – phase 2 KCE reports 81Figure 58. Algorithm for QI 1274, part 2 (prospective database).Long course (total dose >= 45)N° Lymph nodes knownN=4010-11 Lymph nodes examinedN=26412+ Lymph nodes examinedN=137Short course (total dose 1-25)N° Lymph nodes knownN=630-11 Lymph nodes examinedN=2612+ Lymph nodes examinedN=37Other course (total dose 26-44)N° Lymph nodes knownN=250-11 Lymph nodes examinedN=1812+ Lymph nodes examinedN=7Course MISSING:N° Lymph nodes knownN=730-11 Lymph nodes examinedN=2812+ Lymph nodes examinedN=45No neo-adjuvant radiotherapyN° Lymph nodes knownN=10-11 Lymph nodes examinedN=112+ Lymph nodes examinedN=0
KCE Reports 81 PROCARE – phase 2 149(Y)PCRM MENTIONED IN MM IN THE PATHOLOGY REPORTMeasurement in prospective PROCARE database (Figure 59)In the hospital data section of the PROCARE data entry form, the variable ‘AD_V111’ ischecked if the patient underwent rectal surgery. Patients undergoing radical resection(not local) are selected using variables ‘SG_V168’, ‘SG_V210’, ‘SG_V216’ and‘SG_V234’.The (y)pCRM is registered through variable ‘PT_V141’ in the pathology section.Measurement in coupled administrative databaseNo administrative code exists for the (y)pCRM, which are also data that can only beretrieved from the medical file.Figure 59. Algorithm for QI 1275 (prospective database).All patientsN=1071Radical surgeryN=1018SurgeryN=1058Pathologyreport?Pathology reportN=968(y)pCRM mentionedN=70672,93%(y)pCRMmentioned?Surgery?Radicalsurgery?No radical sugeryNo pathology reportN=50(y)pCRM: MISSINGN=262N=40No surgeryN=13
Page 1 and 2:
Assurance de qualitépour le cancer
Page 3 and 4:
Assurance de qualité pour lecancer
Page 5 and 6:
KCE Reports 81B Cancer rectal - pha
Page 7:
KCE Reports 81B Cancer rectal - pha
Page 10 and 11:
vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13:
2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15:
4 PROCARE - phase 2 KCE reports 811
Page 16 and 17:
6 PROCARE - phase 2 KCE reports 81F
Page 19 and 20:
KCE Reports 81 PROCARE - phase 2 92
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
KCE Reports 81 PROCARE - Phase 2 77
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108: KCE Reports 81 PROCARE - phase 2 97
Page 157: KCE Reports 81 PROCARE - phase 2 14
Page 169: KCE Reports 81 PROCARE - phase 2 15
Page 172 and 173: Dépôt légal : D/2008/10.273/39
Page 174 and 175: 35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?